← FDA Warning Letters
Novo Nordisk Inc.
FDA Warning Letter · 2026-03-10 · Center for Drug Evaluation and Research (CDER)
Letter
- Company
- Novo Nordisk Inc.
- Posted Date
- 2026-03-10
- Letter Issue Date
- 2026-03-05
- Issuing Office
- Center for Drug Evaluation and Research (CDER)
Subject
Postmarketing Adverse Drug Experience Reporting Requirements
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown